• Je něco špatně v tomto záznamu ?

Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner

G. Molostvov, M. Gachechiladze, AM. Shaaban, S. Hayward, I. Dean, IHK. Dias, N. Badr, I. Danial, F. Mohammed, V. Novitskaya, L. Paniushkina, V. Speirs, A. Hanby, I. Nazarenko, DR. Withers, S. van Laere, HM. Long, F. Berditchevski

. 2023 ; 42 (3) : 112207. [pub] 20230303

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010635

Grantová podpora
MR/N021738/1 Medical Research Council - United Kingdom
099266/Z/12/Z Wellcome Trust - United Kingdom

The immune microenvironment in breast cancer (BCa) is controlled by a complex network of communication between various cell types. Here, we find that recruitment of B lymphocytes to BCa tissues is controlled via mechanisms associated with cancer cell-derived extracellular vesicles (CCD-EVs). Gene expression profiling identifies the Liver X receptor (LXR)-dependent transcriptional network as a key pathway that controls both CCD-EVs-induced migration of B cells and accumulation of B cells in BCa tissues. The increased accumulation oxysterol ligands for LXR (i.e., 25-hydroxycholesterol and 27-hydroxycholesterol) in CCD-EVs is regulated by the tetraspanin 6 (Tspan6). Tspan6 stimulates the chemoattractive potential of BCa cells for B cells in an EV- and LXR-dependent manner. These results demonstrate that tetraspanins control intercellular trafficking of oxysterols via CCD-EVs. Furthermore, tetraspanin-dependent changes in the oxysterol composition of CCD-EVs and the LXR signaling axis play a key role in specific changes in the tumor immune microenvironment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010635
003      
CZ-PrNML
005      
20230801132543.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.celrep.2023.112207 $2 doi
035    __
$a (PubMed)36867531
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Molostvov, Guerman $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
245    10
$a Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner / $c G. Molostvov, M. Gachechiladze, AM. Shaaban, S. Hayward, I. Dean, IHK. Dias, N. Badr, I. Danial, F. Mohammed, V. Novitskaya, L. Paniushkina, V. Speirs, A. Hanby, I. Nazarenko, DR. Withers, S. van Laere, HM. Long, F. Berditchevski
520    9_
$a The immune microenvironment in breast cancer (BCa) is controlled by a complex network of communication between various cell types. Here, we find that recruitment of B lymphocytes to BCa tissues is controlled via mechanisms associated with cancer cell-derived extracellular vesicles (CCD-EVs). Gene expression profiling identifies the Liver X receptor (LXR)-dependent transcriptional network as a key pathway that controls both CCD-EVs-induced migration of B cells and accumulation of B cells in BCa tissues. The increased accumulation oxysterol ligands for LXR (i.e., 25-hydroxycholesterol and 27-hydroxycholesterol) in CCD-EVs is regulated by the tetraspanin 6 (Tspan6). Tspan6 stimulates the chemoattractive potential of BCa cells for B cells in an EV- and LXR-dependent manner. These results demonstrate that tetraspanins control intercellular trafficking of oxysterols via CCD-EVs. Furthermore, tetraspanin-dependent changes in the oxysterol composition of CCD-EVs and the LXR signaling axis play a key role in specific changes in the tumor immune microenvironment.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a jaterní receptor X $x metabolismus $7 D000071518
650    12
$a nádory prsu $x genetika $7 D001943
650    12
$a oxysteroly $x farmakologie $7 D000072376
650    _2
$a tetraspaniny $7 D059470
650    _2
$a B-lymfocyty $x metabolismus $7 D001402
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gachechiladze, Mariam $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Department of Clinical and Molecular Pathology, Palacky Univerzity, 7779 00 Olomouc, Czech Republic
700    1_
$a Shaaban, Abeer M $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a Hayward, Steven $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a Dean, Isaac $u Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a Dias, Irundika H K $u Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham B4 7ET, UK
700    1_
$a Badr, Nahla $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt
700    1_
$a Danial, Irini $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a Mohammed, Fiyaz $u Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a Novitskaya, Vera $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a Paniushkina, Liliia $u Faculty of Medicine, Institute for Infection Prevention and Hospital Epidemiology, Medical Center - University of Freiburg, 79106 Freiburg, Germany
700    1_
$a Speirs, Valerie $u Leeds Institute of Medical Research, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK; Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
700    1_
$a Hanby, Andrew $u Leeds Institute of Medical Research, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK
700    1_
$a Nazarenko, Irina $u Faculty of Medicine, Institute for Infection Prevention and Hospital Epidemiology, Medical Center - University of Freiburg, 79106 Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
700    1_
$a Withers, David R $u Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
700    1_
$a van Laere, Steven $u Translational Cancer Research Unit Center for Oncological Research, University Antwerp, Antwerp 2610, Belgium
700    1_
$a Long, Heather M $u Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: h.m.long@bham.ac.uk
700    1_
$a Berditchevski, Fedor $u Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: f.berditchevski@bham.ac.uk
773    0_
$w MED00188029 $t Cell reports $x 2211-1247 $g Roč. 42, č. 3 (2023), s. 112207
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36867531 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132539 $b ABA008
999    __
$a ok $b bmc $g 1963215 $s 1196900
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 42 $c 3 $d 112207 $e 20230303 $i 2211-1247 $m Cell reports $n Cell Rep $x MED00188029
GRA    __
$a MR/N021738/1 $p Medical Research Council $2 United Kingdom
GRA    __
$a 099266/Z/12/Z $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

    Možnosti archivace